Negative results of METLung study: an opportunity to better understand the role of MET pathway in advanced NSCLC

Lignende værker

• Two are better than one on progression through MET mechanism for EGFR+ NSCLC patients
  af: Kian, Waleed, et al.
  Udgivet: (2018)
• Maintenance therapy for advanced non‐small cell lung cancer (NSCLC)
  af: Paulus, Valérie, et al.
  Udgivet: (2019)
• The role of erlotinib in advanced NSCLC
  af: Goldsack, N
  Udgivet: (2005)
• Modeling NSCLC Progression: Recent Advances and Opportunities Available
  af: Suleiman, Ahmed Abbas, et al.
  Udgivet: (2013)
• An Opportunity to Better Understand the Impact of Coronaviruses on Immunocompromised Patients
  af: Parisi, Christina
  Udgivet: (2020)